Chris is at the forefront of the emerging field of stem cell and regenerative medicine bioprocessing plus is involved in a number of committees, networks, Scientific Advisory Boards, editorial boards, working groups and initiatives related to the academic, clinical and commercial advancement of stem cells and tissue engineering.

Originally graduating from Imperial College with a degree in molecular biology and St. Thomas's Hospital Medical School with a medical degree, Chris then specialized in surgery. Chris is a Fellow of the Royal College of Surgeons of England, Fellow of the Royal College of Surgeons in Ireland and a Fellow of the Royal Society of Medicine. In addition, he has a PhD in Biochemical Engineering under the supervision of Prof. Peter Dunnill (UCL), leads the Stem Cell + Regenerative Medicine Bioprocess Group at UCL (a team of 20 researchers) and has broad range of expertise in commercial consultancy. Furthermore, Chris has over 10 years of experience at the boardroom level running technology companies.

Chris is also co-founder and co-organizer of the London Regenerative Medicine Network (LRMN), on the Editorial Boards of the journals "Regenerative Medicine" and "Tissue Engineering", Mission Leader of the DTI funded Global Watch Mission "Advanced Cell & Tissue Therapies" and a member of the Steering Committee for the UK National Stem Cell Network (UKNSCN).